De-escalation of corticosteroids and clonal remission in UBA1 mutation-driven VEXAS syndrome with 5-azacytidine

Haematologica. 2024 Oct 1;109(10):3431-3434. doi: 10.3324/haematol.2024.285519.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones* / administration & dosage
  • Adrenal Cortex Hormones* / therapeutic use
  • Azacitidine* / therapeutic use
  • Female
  • Humans
  • Male
  • Mutation*
  • Remission Induction
  • Treatment Outcome
  • Ubiquitin-Activating Enzymes* / genetics

Substances

  • Azacitidine
  • UBA1 protein, human
  • Ubiquitin-Activating Enzymes
  • Adrenal Cortex Hormones